Allogeneic CAR-T therapies deliver scalable, off-the-shelf cancer therapy, while autologous CAR-T therapies provide patient-specific but time-intensive treatment.
Shada Warreth
Advertisement
Shada Warreth is Global Partnerships Implementation senior manger at NIBRT and PhD Candidate at TU Dublin, Ireland.
Articles by Shada Warreth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
